TrueBlue Inc. (TBI)
NYSE NYSE Primary 
TrueBlue (TBI) Reports Q2 Loss, Misses Revenue Estimates
TrueBlue (TBI) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.35 per share a year ago.
TrueBlue (TBI) Reports Q1 Loss, Tops Revenue Estimates
TrueBlue (TBI) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.03 per share a year ago.
TrueBlue (TBI) Soars 5.8%: Is Further Upside Left in the Stock?
TrueBlue (TBI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TrueBlue, Inc. (TBI) Q4 2024 Earnings Call Transcript
TrueBlue, Inc. (NYSE:TBI ) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Taryn Owen - CEO, President & Director Carl Schweihs - EVP & CFO Conference Call Participants Will Brunemann - Northcoast Research Mark Marcon - Baird Marc Riddick - Sidoti Operator Greetings, and welcome to the TrueBlue Fourth Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
TrueBlue (TBI) Reports Q4 Loss, Tops Revenue Estimates
TrueBlue (TBI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to earnings of $0.08 per share a year ago.
All You Need to Know About TrueBlue (TBI) Rating Upgrade to Strong Buy
TrueBlue (TBI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TrueBlue (TBI) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, TrueBlue (TBI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Wall Street Analysts See a 50.07% Upside in TrueBlue (TBI): Can the Stock Really Move This High?
The mean of analysts' price targets for TrueBlue (TBI) points to a 50.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Bears are Losing Control Over TrueBlue (TBI), Here's Why It's a 'Buy' Now
TrueBlue (TBI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Wall Street Analysts Think TrueBlue (TBI) Could Surge 47.06%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 47.1% in TrueBlue (TBI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
TrueBlue, Inc. (TBI) Q3 2024 Earnings Call Transcript
TrueBlue, Inc. (NYSE:TBI ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Taryn Owen - President and CEO Carl Schweihs - CFO Conference Call Participants Ryan Griffin - BMO Capital Markets Mark Marcon - Baird Kartik Mehta - Northcoast Research Marc Riddick - Sidoti & Company Operator Greetings and welcome to the TrueBlue Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
TrueBlue (TBI) Reports Q3 Loss, Misses Revenue Estimates
TrueBlue (TBI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.16 per share a year ago.
